Meyers, Juliana; Yu, Yanni; Kaye, James; Davis, Keith - In: Applied Health Economics and Health Policy 11 (2013) 3, pp. 275-286
Younger patients with fewer comorbidities were more likely to receive chemotherapy and had longer survival. AML is associated with a substantial economic burden, and treatment outcomes appear to be suboptimal, with limited therapy options currently available. </AbstractSection> Copyright Springer International...